Page results
-
Information about having a gadolinium-based contrast agent for MRI examinations while breastfeeding.
-
This page aims to help you decide if a post-dates induction of labour is the right decision for you and your baby.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
The UCLH children’s FGC/M clinic provides specialist care for children and adolescents who have undergone or are at risk of FGC/M.
-
This step-by-step guide explains how you can give yourself an injection of bortezomib at home.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
The Maternal Medicine team provides care for women with pre-existing medical disorders or pregnancy-related medical conditions. We work in a multidisciplinary team of doctors and midwives in order to provide the best standard of care for women and their babies.
-
Patient Partners are patients, carers, families and people with lived experience of a specific issue or service. UCLH is committed to involving patients, carers, and members of the public in planning, developing, delivering, and monitoring the services we provide. Involving patients and the public in decision-making is crucial to ensuring that those services are what patients want and need.
-
This page provides information about achalasia and its diagnosis and treatment.
-
Infection inpatients offers a variety of different specialities including Infectious Diseases and Tropical Medicine, Respiratory Medicine and Rheumatology. We are also the inpatient ward to the Hospital of Tropical Diseases.
File results
-
FOI/2024/0403 - Risk Policy and corporate risk register
-
FOI/2024/0406 - Staff and patient discrimination complaints in 2021, 2022 and 2023
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0412 - Healthcare travel costs scheme for patients
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0420 - Commercialisation of NHS patient data
-
FOI/2024/0421 - Capital staffing nurses/ approved framework agencies/ escalated rates
-
FOI/2024/0423 - Giant cell arteritis (GCA) patient treatment